Koyfin Home > Directory > Health Care > Aldeyra Therapeu

Aldeyra Therapeu Price Chart ALDX

Historical daily share price chart and data for Aldeyra Therapeu since 2014 adjusted for splits and dividends. The latest closing price for Aldeyra Therapeu as of September 24, 2020 is $6.77.
  • In 2020 the stock opened at $5.90 and closed at $6.77 for a gain of 13% YTD.
  • In 2019 the stock opened at $8.21 and closed at $5.81 for a loss of -41%.
  • In 2018 the stock opened at $6.90 and closed at $8.30 for a gain of 17%.
  • In 2017 the stock opened at $5.35 and closed at $6.80 for a gain of 21%.
View Chart On Koyfin

Aldeyra Therapeu Summary

Stock Symbol: ALDX

Aldeyra Therapeu Company Info

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company’s lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, a sight-threatening retinal disease. The company’s portfolio also consists of ADX-1612, a small molecule heat shock protein 90 (Hsp90) inhibitor for the treatment of lymphoproliferative diseases; and reactive aldehyde species that are pro-inflammatory (RASP) scavengers, such as ADX-629 for treating autoimmune diseases, as well as ADX-103 for the treatment of retinal diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was founded in 2004 and is headquartered in Lexington, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
81.73 %
30D Volatility
Hedge Fund Held
17.27 %

Last 10 Days of ALDX Prices